30 July 2019 by Krishna Prasad Conference talk Krishna Prasad - What do regulators expect from phase 2 trials and adaptive designs? Share About the author Krishna Prasad EMA United Kingdom More from this author Krishna Prasad - Precision medicine & PAH (Regulatory / EMA Approach) Krishna Prasad - What you need to do to qualify a Biomarker to inform a clinical trial
